Article Details

POINT Biopharma and Isotopia announce Lutetium-177 clinical supply agreement

Retrieved on: 2021-07-26 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

POINT Biopharma and Isotopia announce Lutetium-177 clinical supply agreement. View article details on hiswai:

Excerpt

INDIANAPOLIS, INDIANA and PETACH TIKVA, Israel, – POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, ...

Article found on: www.dotmed.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up